Graegis Pharmaceuticals Limited enters members' voluntary liquidation
Active Company no. 13680871 Incorporated Oct 2021 CB postcode area
C/O The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH
The most recent insolvency notice for Graegis Pharmaceuticals Limited is an Appointment of liquidators (MVL), published 12 October 2026 in The London Gazette. The office holder is James Hopkirk (IP No. 21150) of Kreston Reeves LLP, 2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent, ME4 4QZ, appointed 30 September 2026. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Last filed balance sheet
Accounts filed on paper only.
Insolvency notices (3)
-
Appointment of liquidators (MVL) 12 Oct 2026
The notice announces that the members of Graegis Pharmaceuticals Limited have appointed James Hopkirk of Kreston Reeves LLP as liquidator for a members voluntary liquidation effective 30 September 2026.
-
Resolution for winding up (MVL) 12 Oct 2026
The members of Graegis Pharmaceuticals Limited resolved to voluntarily wind up the company and appointed James Hopkirk of Kreston Reeves LLP as liquidator on 30 September 2026.
-
Notices to creditors (MVL) 12 Oct 2026
The liquidator of Graegis Pharmaceuticals Ltd announces final creditor claims and intends to distribute remaining funds to shareholders after a members’ voluntary liquidation.
Owed money by Graegis Pharmaceuticals Limited?
A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.
Related guidance
Frequently asked questions
Is Graegis Pharmaceuticals Limited in financial difficulty?
No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Graegis Pharmaceuticals Limited (company no. 13680871) is a Appointment of liquidators (MVL), published 12 October 2026 in The London Gazette.
What were Graegis Pharmaceuticals Limited's last filed accounts?
Accounts filed on paper only for Graegis Pharmaceuticals Limited at Companies House.
How many insolvency notices does Graegis Pharmaceuticals Limited have?
Graegis Pharmaceuticals Limited has 3 insolvency notices recorded in The London Gazette, the most recent being a Appointment of liquidators (MVL) on 12 October 2026.
Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.